Sabrina Kraus

6PUBLICATIONS
70CO-AUTHORS
Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Nanotoxicology, health and safety
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Aug 18, 2026
Treatment sequence with gilteritinib and allogeneic haematopoietic stem cell transplantation in relapsed/refractory FMS-like tyrosine kinase 3 (FLT3)-mutated acute myeloid leukaemia patients: A multicentre real-world study.

|May 05, 2025
Myeloablative Radioligand Therapy Targeting C-X-C Motif Chemokine Receptor 4 in Advanced Multiple Myeloma.

Niklas Dreher, Anna-Lena Dörrler, Sabrina Kraus

|Feb 05, 2024
Impaired T cells and "memory-like" NK-cell reconstitution is linked to late-onset HCMV reactivation after letermovir cessation.

Chris David Lauruschkat, Ihsan Muchsin, Alice Felicitas Rein

|Dec 21, 2023
Identification of novel canonical and cryptic HCMV-specific T-cell epitopes for HLA-A∗03 and HLA-B∗15 via peptide-PRISM.

Alice Felicitas Rein, Chris David Lauruschkat, Ihsan Muchsin

|Aug 17, 2016
Exogenous TNFR2 activation protects from acute GvHD via host T reg cell expansion.

Martin Chopra, Marlene Biehl, Tim Steinfatt

Pageof 1

Frequent Collaborators

5 joint publications

Hermann Einsele

2 joint publications

Lars Dölken

2 joint publications

Sebastian E Serfling

2 joint publications

Florian Erhard